1 year return (CAGR)
53.13%
Ovid Therapeutics Inc Exchange (NASDAQ, USD)
OVID
2.45
+0.19 (+8.41%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-11.71%
5 year return (CAGR)
-7.51%
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
478.48M
Price/Sales
302.26
Ent value
489.24M
Price/Book
2.28
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-29.81%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 2.26 |
| Daily high | 2.50 |
| Daily low | 2.21 |
| Daily Volume | 2.05M |
| All-time high | 15.00 |
| 1y analyst estimate | 5.92 |
| Beta | 0.25 |
| EPS (TTM) | -0.47 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 16 Mar 2026 |
Downside potential
Loading...
Downside potential data
| OVID | S&P500 | |
| Current price drop from All-time high | -82.93% | -1.25% |
| Highest price drop | -98.30% | -56.47% |
| Date of highest drop | 10 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -75.39% | -10.65% |
| Avg time to new high | 265 days | 12 days |
| Max time to new high | 2374 days | 1805 days |
News
